RTW INVESTMENTS, LP Acquires Significant Stake in UroGen Pharma Ltd
| RCKT Stock | USD 14.39 0.19 1.34% |
Slightly above 61% of all Rocket Pharmaceuticals' private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Rocket Pharmaceuticals suggests that some traders are interested. Rocket Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Rocket Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Rocket |
Overview of Recent Transaction by RTW INVESTMENTS, LP On September 30, 2024, RTW INVESTMENTS, LP , a prominent investment
Read at gurufocus.com
 |
Rocket Pharmaceuticals Fundamental Analysis
We analyze Rocket Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rocket Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rocket Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Rocket Pharmaceuticals is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Rocket Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rocket Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Rocket Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Rocket Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Rocket Pharmaceuticals Related Equities
| MGTX | MeiraGTx Holdings | 3.36 | ||||
| PLRX | Pliant Therapeutics | 2.00 | ||||
| STOK | Stoke Therapeutics | 1.68 | ||||
| DAWN | Day One | 1.53 | ||||
| SNDX | Syndax Pharmaceuticals | 1.27 | ||||
| PCVX | Vaxcyte | 0.38 | ||||
| REPL | Replimune | 0.21 | ||||
| SLDB | Solid Biosciences | 0.18 | ||||
| MRUS | Merus BV | 0.29 | ||||
| RYTM | Rhythm Pharmaceuticals | 0.34 | ||||
| INZY | Inozyme Pharma | 0.37 | ||||
| CYTK | Cytokinetics | 0.69 | ||||
| QURE | Uniqure NV | 0.83 | ||||
| RGNX | Regenxbio | 0.90 | ||||
| MIRM | Mirum Pharmaceuticals | 0.92 | ||||
| RVMD | Revolution Medicines | 1.25 | ||||
| VRDN | Viridian Therapeutics | 1.46 | ||||
| STRO | Sutro Biopharma | 1.49 | ||||
| DYN | Dyne Therapeutics | 1.67 | ||||
| LRMR | Larimar Therapeutics | 4.67 |
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.